The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.
A new drug has cured 20% of patients with a chronic, cancer-causing disease — which was previously incurable. A viral ...
Health and Me on MSN
Potential 'Functional Cure' For Hepatitis B: Trial Give Hope To Millions
The recent publication of a research paper on a drug trial has given hope to millions of patients with chronic hepatitis B ...
Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...
After treatment with bepirovirsen, however, 19% of patients achieved the strictly defined “functional cure” criteria. For the ...
The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical ...
Two replicate phase 3 randomized controlled trials involving patients with chronic hepatitis B virus (HBV) infection demonstrate a functional cure after the discontinuation of conventional long-term ...
Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...
New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results